Neuropsychological Outcome After Cardiac Arrest

NCT03543371 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-12-19

No results posted yet for this study

Summary

This study is a sub-study to the large pragmatic Target Temperature Management 2 Trial (TTM2-trial, ClinicalTrials.gov Identifier: NCT02908308), assessing effectiveness of controlled hypothermia after out-of-hospital cardiac arrest (OHCA).

This study is designed to provide detailed information on cognition after OHCA and its relationship to associated factors as emotional function, fatigue, and sleep. A secondary aim is to utilize this information to validate a neurocognitive screening battery used 6 months after OHCA in the TTM2-trial.

Approximately 7 and 24 months after OHCA, survivors at selected TTM2 study sites will perform a standardized neuropsychological assessment including performance-based tests of cognition and questionnaires of behavioral and emotional function, fatigue, and insomnia. At 1:1 ratio, a control group of myocardial infarction (MI) patients but no occurrence of cardiac arrest will be recruited and perform the same test battery. Group differences at 7 and 24 months will be analyzed per cognitive domain (verbal, visual/constructive, short-term working memory, episodic memory, processing speed, executive functions). Results of the OHCA survivors on the TTM2 neurocognitive screening battery will be compared with neuropsychological test results at 7 months time.

Conditions

  • Heart Arrest, Out-Of-Hospital
  • Hypoxia-Ischemia, Brain
  • Cognition Disorders
  • Psychological Distress
  • Fatigue
  • Insomnia

Interventions

DIAGNOSTIC_TEST

Neuropsychological assessment

Standardized neuropsychological battery consisting of the following tests and questionnaires: Wechsler Adult Intelligence Scale - Fourth Edition (WAIS-IV) Vocabulary, Delis-Kaplan Executive Function System (D-KEFS) Verbal Fluency, WAIS-IV Block Design, WAIS-IV Matrix Reasoning, WAIS-IV Digit Span, Wechsler Memory Scale - Third Edition (WMS-III) Spatial Span, Rey Auditory Verbal Learning Test (RAVLT), WMS-III Logical Memory, Brief Visuospatial Memory Test-Revised (BVMT-R), Trail Making Test (TMT) A \& B, D-KEFS Color Word Interference Test, Behavioral Assessment of the Dysexecutive Syndrome Dysexecutive Questionnaire (BADS DEX), Multidimensional Fatigue Inventory (MFI-20), Minimal Insomnia Symptom Scale (MISS), Hospital Anxiety and Depression Scale (HADS).

Sponsors & Collaborators

  • Lund University

    collaborator OTHER
  • Halmstad County Hospital

    collaborator OTHER
  • Sahlgrenska University Hospital

    collaborator OTHER
  • Mid and South Essex NHS Foundation Trust

    collaborator OTHER
  • Cardiff and Vale University Health Board

    collaborator OTHER_GOV
  • Aarhus University Hospital

    collaborator OTHER
  • Region Skane

    lead OTHER

Principal Investigators

  • Niklas Nielsen, MD, PhD · Lund University

  • Gisela Lilja, PhD, OT · Lund University

  • Tobias Cronberg, MD, PhD · Lund University

  • Susanna Vestberg, PhD, Lic.Psych. · Lund University

  • Erik Blennow Nordström, PhD, Lic.Psych. · Lund University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-13
Primary Completion
2021-01-11
Completion
2022-05-23

Countries

  • Denmark
  • Sweden
  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03543371 on ClinicalTrials.gov